Connor R I, Mohri H, Cao Y, Ho D D
Aaron Diamond AIDS Research Center, New York University School of Medicine, New York 10016.
J Virol. 1993 Apr;67(4):1772-7. doi: 10.1128/JVI.67.4.1772-1777.1993.
The rate of clinical progression is variable among individuals infected with human immunodeficiency virus type 1 (HIV-1). Changes in viral burden which correlate with disease status have been demonstrated in cross-sectional studies; however, a detailed longitudinal study of the temporal relationship between viral burden, CD4+ T-cell numbers, and clinical status throughout the course of infection has not been reported. Multiple longitudinal blood samples were obtained from four HIV-1-infected individuals with clinically divergent profiles. Levels of HIV-1 were measured in sequential samples of peripheral blood mononuclear cells, using both end-point dilution cultures and quantitative polymerase chain reaction methods. Serial HIV-1 isolates from each case were also evaluated to determine their biological properties in vitro. For the three patients with clinical progression, a dramatic increase in the level of HIV-1 was observed concurrent with or prior to a marked drop in CD4+ T lymphocytes. This increase in viral burden was temporally associated with the emergence of a more cytopathic viral phenotype. In contrast, consistently low levels of HIV-1 were observed in the one patient who was clinically and immunologically stable for more than a decade. Moreover, viral isolates from this patient were less cytopathic in vitro compared with HIV-1 isolates from those patients with disease progression. The temporal association between increased viral burden and CD4+ T-cell decline suggests a direct role for HIV-1 in the cytopathology of CD4+ T cells in vivo. Our results indicate that the pathogenic mechanisms responsible for CD4+ T-cell depletion may be related to both quantitative and qualitative changes in HIV-1.
1型人类免疫缺陷病毒(HIV-1)感染者的临床进展速度因人而异。横断面研究已证明病毒载量的变化与疾病状态相关;然而,尚未有关于感染全过程中病毒载量、CD4+ T细胞数量和临床状态之间时间关系的详细纵向研究报告。从四名临床特征不同的HIV-1感染者身上采集了多份纵向血样。使用终点稀释培养法和定量聚合酶链反应方法,对外周血单核细胞的连续样本进行HIV-1水平检测。还对每个病例的系列HIV-1分离株进行了评估,以确定其体外生物学特性。对于三名出现临床进展的患者,在CD4+ T淋巴细胞显著下降之时或之前,观察到HIV-1水平急剧上升。病毒载量的这种增加在时间上与更具细胞病变性的病毒表型的出现相关。相比之下,在一名临床和免疫状态稳定超过十年的患者中,观察到HIV-1水平持续较低。此外,与疾病进展患者的HIV-1分离株相比,该患者的病毒分离株在体外的细胞病变性较小。病毒载量增加与CD4+ T细胞下降之间的时间关联表明HIV-1在体内CD4+ T细胞的细胞病理学中起直接作用。我们的结果表明,导致CD4+ T细胞耗竭的致病机制可能与HIV-1的数量和质量变化有关。